Last reviewed · How we verify

NCT07348991

Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG

Not yet recruiting Last updated 10 February 2026
What this trial tests

trial testing digital single-channel ECG recording in Atrial Fibrillation in 300 participants. Not yet recruiting.

Timeline
31 December 2026
Primary endpoint
30 June 2027
30 May 2028

Quick facts

Lead sponsorI.M. Sechenov First Moscow State Medical University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment300
Start date31 December 2026
Primary completion30 June 2027
Estimated completion30 May 2028

Drugs / interventions tested

Conditions studied

Sponsor

I.M. Sechenov First Moscow State Medical University

Who can join

18 and older, any sex, with Atrial Fibrillation or Atrioventricular Block, Second and Third Degree. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the preoperative examination, in addition to the standard examination recommended before high-risk cardiac surgeries, a digital single-lead ECG is recorded using portable CardioQUARK devices. This ECG is analyzed for time, amplitude, and frequency parameters-more than 200 parameters per cardiac cycle. Additionally, the available parameters of a standard 12-lead ECG recording are determined. All parameters of both single-lead and 12-lead ECGs will be included in a multivariate regression analysis to determine the optimal method for predicting atrial fibrillation, life-threatening cardiac arrhythmias, and conduction abnormalities in the perioperative period after high-risk cardiac procedures. The study will include patients undergoing high-risk cardiac surgeries, such as those on the heart, aorta, esophagus, pancreas, liver, and lungs, as well as high-risk oncological surgeries. A partial analysis will also be performed depending on the type of intervention. Rhythm and conduction disturbances will be recorded during surgery, as well as in the postoperative period, using ECG monitors, 24-hour ECG monitoring, and repeated recordings of a standard ECG when complaints or signs of unstable hemodynamics arise

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other I.M. Sechenov First Moscow State Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07348991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing